Dr. Doured Daghistani
M.D. | Pediatric Hematology-Oncology | Male
Dr. Doured Daghistani, M.D. is a Miami, Florida based Pediatric doctor with medical specialization in
Pediatric Hematology-Oncology.
Current practice location of Dr. Doured Daghistani is
8900 N Kendall Dr, Miami Cancer Center, Miami, Florida - 33176-2118. He can be contacted on phone at
786-596-2000.
Dr. Doured Daghistani is a sole proprietor of his business.
NPI number (Unique professional ID) for Dr. Doured Daghistani is
1871580118 which was assigned by NPPES on 03 Oct, 2005 and it was last updated on 22 Feb, 2017.
Dr. Doured Daghistani license number is
ME0047164 for Pediatrics Pediatric Hematology-Oncology (2080P0207X) in Florida.
Dr. Doured Daghistani is trained in the combination of pediatrics, hematology and oncology to recognize and manage pediatric blood disorders and cancerous diseases.
Complete Profile:
Dr. Doured Daghistani basic information including his official name, gender, specialization, credentials etc. are as mentioned below.
Specialization : | Pediatrics Pediatric Hematology-Oncology |
---|
Provider Name : | Dr. Doured Daghistani |
---|
Credential : | M.D. |
---|
Gender : | Male |
---|
Business Address:
Dr. Doured Daghistani address, contact phone number and fax are as below. Patients can directly walkin to the clinic or can call on the below given phone number for appointment.
Primary Address : | 8900 N Kendall Dr, Miami Cancer Center Miami, FL, 33176-2118 United States |
---|
Phone Number : | 786-596-2000 |
---|
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number : | 1871580118 |
---|
NPI Entity Type : | Individual |
---|
First Enrolment Date : | 03 Oct, 2005 |
---|
Last Updated On : | 22 Feb, 2017 |
---|
Medicare Participation:
Dr. Doured Daghistani participates in medicare and accepts medicare insurance either directly or through association with group practice or medical facility.
Medicare PECOS ID : | 3678519345 |
---|
Medicare Enrollment ID : | I20050705000052 |
---|
Primary Specialty : | Pediatric Medicine |
---|
Medical School : | Other |
---|
Graduation Year : | 1981 |
---|
Accepts Medicare? | Yes. Dr. Doured Daghistani accepts medicare insurance. |
---|
Group Practice Association:
Dr. Doured Daghistani is associated with following Group Practice Organizations. Group practices are practice of medicine by a group of physicians who share their premises and other resources. Following list states all the group name with which Dr. Doured Daghistani is associated with along with the number of members in that group. He may also accept medicare indirectly via these group practices.
Organisation Name : | Group Practice ID | No. of Members | Practice Address | Group Accepts Medicare |
---|
Baptist Health Medical Group Oncology Llc | 1456676519 | 152 | 8900 N Kendall Dr Miami, FL - 331762118 | Yes |
Licenses and Specialities:
Physicians/Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Doured Daghistani are as mentioned. Primary taxonomy code for Dr. Doured Daghistani, M.D. is
2080P0207X (Pediatrics Pediatric Hematology-Oncology).
Taxonomy Code | Speciality | Primary | License No. | State |
---|
2080P0207X | Pediatrics Pediatric Hematology-Oncology | Yes | ME0047164 | FL |
Mailing Address:
Mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned business address only.
Mailing Address : | 9350 Sunset Dr, Ste 200 Miami, FL, 33173-3286 United States |
---|
Phone Number : | 786-594-4210 |
---|
Business Location:
Patients can refer following map for directions to
Dr. Doured Daghistani practice address. Don't forget to take prior appointment before visiting.
** Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 January, 2024.